Advanced search
1 file | 350.72 KB Add to list

Correlation between epidermal growth factor receptor-specific nanobody uptake and tumor burden: a tool for noninvasive monitoring of tumor response to therapy

(2011) MOLECULAR IMAGING AND BIOLOGY. 13(5). p.940-948
Author
Organization
Keywords
WILD-TYPE, RENAL UPTAKE, MICE, EXPRESSION, MUTATIONS, GEFITINIB, Epidermal growth factor receptor (EGFR), Cetuximab, Erlotinib, (99m)Tc-7C12-nanobody, Specificity, Therapy monitoring, Bioluminescence imaging, IN-VIVO, ANTI-EGFR NANOBODIES, PINHOLE SPECT/MICRO-CT, CELL LUNG-CANCER

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 350.72 KB

Citation

Please use this url to cite or link to this publication:

MLA
Gainkam, Lea Olive Tchouate, Marleen Keyaerts, Vicky Caveliers, et al. “Correlation Between Epidermal Growth Factor Receptor-specific Nanobody Uptake and Tumor Burden: a Tool for Noninvasive Monitoring of Tumor Response to Therapy.” MOLECULAR IMAGING AND BIOLOGY 13.5 (2011): 940–948. Print.
APA
Gainkam, L. O. T., Keyaerts, M., Caveliers, V., Devoogdt, N., Vanhove, C., Van Grunsven, L., Muylderman, S., et al. (2011). Correlation between epidermal growth factor receptor-specific nanobody uptake and tumor burden: a tool for noninvasive monitoring of tumor response to therapy. MOLECULAR IMAGING AND BIOLOGY, 13(5), 940–948.
Chicago author-date
Gainkam, Lea Olive Tchouate, Marleen Keyaerts, Vicky Caveliers, Nick Devoogdt, Christian Vanhove, Leo Van Grunsven, Serge Muylderman, and Tony Lahoutte. 2011. “Correlation Between Epidermal Growth Factor Receptor-specific Nanobody Uptake and Tumor Burden: a Tool for Noninvasive Monitoring of Tumor Response to Therapy.” Molecular Imaging and Biology 13 (5): 940–948.
Chicago author-date (all authors)
Gainkam, Lea Olive Tchouate, Marleen Keyaerts, Vicky Caveliers, Nick Devoogdt, Christian Vanhove, Leo Van Grunsven, Serge Muylderman, and Tony Lahoutte. 2011. “Correlation Between Epidermal Growth Factor Receptor-specific Nanobody Uptake and Tumor Burden: a Tool for Noninvasive Monitoring of Tumor Response to Therapy.” Molecular Imaging and Biology 13 (5): 940–948.
Vancouver
1.
Gainkam LOT, Keyaerts M, Caveliers V, Devoogdt N, Vanhove C, Van Grunsven L, et al. Correlation between epidermal growth factor receptor-specific nanobody uptake and tumor burden: a tool for noninvasive monitoring of tumor response to therapy. MOLECULAR IMAGING AND BIOLOGY. 2011;13(5):940–8.
IEEE
[1]
L. O. T. Gainkam et al., “Correlation between epidermal growth factor receptor-specific nanobody uptake and tumor burden: a tool for noninvasive monitoring of tumor response to therapy,” MOLECULAR IMAGING AND BIOLOGY, vol. 13, no. 5, pp. 940–948, 2011.
@article{2118656,
  author       = {{Gainkam, Lea Olive Tchouate and Keyaerts, Marleen and Caveliers, Vicky and Devoogdt, Nick and Vanhove, Christian and Van Grunsven, Leo and Muylderman, Serge and Lahoutte, Tony}},
  issn         = {{1536-1632}},
  journal      = {{MOLECULAR IMAGING AND BIOLOGY}},
  keywords     = {{WILD-TYPE,RENAL UPTAKE,MICE,EXPRESSION,MUTATIONS,GEFITINIB,Epidermal growth factor receptor (EGFR),Cetuximab,Erlotinib,(99m)Tc-7C12-nanobody,Specificity,Therapy monitoring,Bioluminescence imaging,IN-VIVO,ANTI-EGFR NANOBODIES,PINHOLE SPECT/MICRO-CT,CELL LUNG-CANCER}},
  language     = {{eng}},
  number       = {{5}},
  pages        = {{940--948}},
  title        = {{Correlation between epidermal growth factor receptor-specific nanobody uptake and tumor burden: a tool for noninvasive monitoring of tumor response to therapy}},
  url          = {{http://dx.doi.org/10.1007/s11307-010-0428-4}},
  volume       = {{13}},
  year         = {{2011}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: